FDA Clears Blood Test for Alzheimer’s Assessment in Primary Care
The test measures phosphorylated Tau 181 protein to help rule out Alzheimer's-related amyloid pathology in patients 55 and older.
The test measures phosphorylated Tau 181 protein to help rule out Alzheimer's-related amyloid pathology in patients 55 and older.
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
A novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
The multi-year collaboration aims to integrate robotic liquid-handling capabilities with BD single-cell instruments to accelerate disease research and drug development.
The single-plex assay, for research use only, measures brain-derived phosphorylated tau 217 from plasma, serum, and dried blood spots without requiring cerebrospinal fluid collection.